Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00MCJ
|
||||
| Former ID |
DNC003612
|
||||
| Drug Name |
6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526914] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H12N2O
|
||||
| Canonical SMILES |
C1=CC=C2C=C(C(=O)C=CC2=C1)C3=NC4=CC=CC=C4N3
|
||||
| InChI |
1S/C18H12N2O/c21-17-10-9-12-5-1-2-6-13(12)11-14(17)18-19-15-7-3-4-8-16(15)20-18/h1-11H,(H,19,20)
|
||||
| InChIKey |
OZPIXWTVOIXFBH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | Inhibitor | [526914] | |
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.